Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dr Diane Jorkasky joins Aileron

This article was originally published in Scrip

Executive Summary

Aileron Therapeutics (US) has appointed Dr Diane Jorkasky senior vice-president, head of development and chief medical officer. Dr Jorkasky joins after almost 10 years at Pfizer, where she most recently served as vice-president of development, head of worldwide clinical research operations and leader of the operational excellence board for development. Aileron was first funded in 2005 by Apple Tree Partners to develop and advance a new therapeutic modality and class of drugs called Stapled Peptides, which are based on discoveries

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC004898

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel